| CGV | FNDC | CGV / FNDC | |
| Gain YTD | 10.067 | 11.538 | 87% |
| Net Assets | 133M | 3.1B | 4% |
| Total Expense Ratio | 1.25 | 0.39 | 321% |
| Turnover | 92.00 | 16.00 | 575% |
| Yield | 4.86 | 3.40 | 143% |
| Fund Existence | 10 years | 13 years | - |
| CGV | FNDC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | N/A |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 67% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 67% | 2 days ago 78% |
| Advances ODDS (%) | 4 days ago 81% | 3 days ago 81% |
| Declines ODDS (%) | 2 days ago 69% | N/A |
| BollingerBands ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 53% | 2 days ago 74% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBE | 84.44 | 0.32 | +0.38% |
| Invesco Biotechnology & Genome ETF | |||
| GLBL | 28.11 | N/A | N/A |
| Pacer MSCI World Industry Advantage ETF | |||
| DDTS | 22.45 | -0.05 | -0.22% |
| Innovator Eq Dual Drctnl 10 Buf ETF -Sep | |||
| USXF | 67.66 | -0.32 | -0.47% |
| iShares® ESG Advanced MSCI USA ETF | |||
| TGLR | 40.80 | -0.24 | -0.59% |
| Wedbush Laffer Tengler New Era Value ETF | |||
A.I.dvisor indicates that over the last year, CGV has been loosely correlated with MFG. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CGV jumps, then MFG could also see price increases.